In the past 5 years, Jingjing Ye has led six projects:
1. The role and mechanism of PDCD5 gene mutation in hypertrophic cardiomyopathy, funded by the National Natural Science Foundation of China Youth Project.
2. The role and mechanism of PDCD5 in regulating skeletal muscle insulin resistance, funded by the Beijing Natural Science Foundation.
3. The role and mechanism of PDCD5 gene mutation in hypertrophic cardiomyopathy, funded by the Peking University Health Science Center Youth Cultivation Project.
4. Mechanism of PDCD5 regulating skeletal muscle insulin resistance by stabilizing IRS1, funded by the Peking University People's Hospital Research and Development Fund Clinical Medicine + X Cultivation Project.
5. Mechanism of PDCD5 mutation involvement in hypertrophic cardiomyopathy through calcium signaling pathway, funded by the Peking University People's Hospital Research and Development Fund Youth Research Cultivation Project.
6. Mechanism of PDCD5 involvement in regulating acute lung injury caused by hemorrhagic shock through HIF1α pathway, funded by the Peking University People's Hospital Research and Development Fund Academic Rising Star Project.
In the past 5 years, she has published 7 SCI papers as the first author, with a total impact factor of 60.4, the highest being 23.21.
